These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

304 related items for PubMed ID: 16510582

  • 1. Interleukin-23-expressing bone marrow-derived neural stem-like cells exhibit antitumor activity against intracranial glioma.
    Yuan X, Hu J, Belladonna ML, Black KL, Yu JS.
    Cancer Res; 2006 Mar 01; 66(5):2630-8. PubMed ID: 16510582
    [Abstract] [Full Text] [Related]

  • 2. The use of interleukin 12-secreting neural stem cells for the treatment of intracranial glioma.
    Ehtesham M, Kabos P, Kabosova A, Neuman T, Black KL, Yu JS.
    Cancer Res; 2002 Oct 15; 62(20):5657-63. PubMed ID: 12384520
    [Abstract] [Full Text] [Related]

  • 3. Induction of potent antitumor immunity by intratumoral injection of interleukin 23-transduced dendritic cells.
    Hu J, Yuan X, Belladonna ML, Ong JM, Wachsmann-Hogiu S, Farkas DL, Black KL, Yu JS.
    Cancer Res; 2006 Sep 01; 66(17):8887-96. PubMed ID: 16951206
    [Abstract] [Full Text] [Related]

  • 4. Sequential delivery of interferon-alpha gene and DCs to intracranial gliomas promotes an effective antitumor response.
    Tsugawa T, Kuwashima N, Sato H, Fellows-Mayle WK, Dusak JE, Okada K, Papworth GD, Watkins SC, Gambotto A, Yoshida J, Pollack IF, Okada H.
    Gene Ther; 2004 Nov 01; 11(21):1551-8. PubMed ID: 15343358
    [Abstract] [Full Text] [Related]

  • 5. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
    Ojima T, Iwahashi M, Nakamura M, Matsuda K, Naka T, Nakamori M, Ueda K, Ishida K, Yamaue H.
    Int J Oncol; 2006 Apr 01; 28(4):947-53. PubMed ID: 16525645
    [Abstract] [Full Text] [Related]

  • 6. Tumor-induced interleukin 10 suppresses the ability of splenic dendritic cells to stimulate CD4 and CD8 T-cell responses.
    Yang AS, Lattime EC.
    Cancer Res; 2003 May 01; 63(9):2150-7. PubMed ID: 12727833
    [Abstract] [Full Text] [Related]

  • 7. Repeated restraint stress impairs the antitumor T cell response through its suppressive effect on Th1-type CD4+ T cells.
    Li T, Harada M, Tamada K, Abe K, Nomoto K.
    Anticancer Res; 1997 May 01; 17(6D):4259-68. PubMed ID: 9494518
    [Abstract] [Full Text] [Related]

  • 8. Cytokine gene therapy of gliomas: induction of reactive CD4+ T cells by interleukin-4-transfected 9L gliosarcoma is essential for protective immunity.
    Giezeman-Smits KM, Okada H, Brissette-Storkus CS, Villa LA, Attanucci J, Lotze MT, Pollack IF, Bozik ME, Chambers WH.
    Cancer Res; 2000 May 01; 60(9):2449-57. PubMed ID: 10811123
    [Abstract] [Full Text] [Related]

  • 9. [Effect of bone marrow stromal cells transfected with interleukin 18 on growth of intracranial glioma in rats].
    Li CH, Jiao BH.
    Ai Zheng; 2007 Jan 01; 26(1):38-43. PubMed ID: 17222365
    [Abstract] [Full Text] [Related]

  • 10. In situ adenoviral interleukin 12 gene transfer confers potent and long-lasting cytotoxic immunity in glioma.
    Liu Y, Ehtesham M, Samoto K, Wheeler CJ, Thompson RC, Villarreal LP, Black KL, Yu JS.
    Cancer Gene Ther; 2002 Jan 01; 9(1):9-15. PubMed ID: 11916248
    [Abstract] [Full Text] [Related]

  • 11. Absence of major histocompatibility complex class I on neural stem cells does not permit natural killer cell killing and prevents recognition by alloreactive cytotoxic T lymphocytes in vitro.
    Mammolenti M, Gajavelli S, Tsoulfas P, Levy R.
    Stem Cells; 2004 Jan 01; 22(6):1101-10. PubMed ID: 15536199
    [Abstract] [Full Text] [Related]

  • 12. Embryonic stem cell-derived dendritic cells expressing glypican-3, a recently identified oncofetal antigen, induce protective immunity against highly metastatic mouse melanoma, B16-F10.
    Motomura Y, Senju S, Nakatsura T, Matsuyoshi H, Hirata S, Monji M, Komori H, Fukuma D, Baba H, Nishimura Y.
    Cancer Res; 2006 Feb 15; 66(4):2414-22. PubMed ID: 16489048
    [Abstract] [Full Text] [Related]

  • 13. [Effects of interferons on syngeneic murine malignant glioma-specific killer T cell].
    Yamasaki T, Yamashita J, Handa H, Namda Y, Hanaoka M.
    No Shinkei Geka; 1983 Oct 15; 11(10):1059-67. PubMed ID: 6196674
    [Abstract] [Full Text] [Related]

  • 14. Bone marrow retaining colitogenic CD4+ T cells may be a pathogenic reservoir for chronic colitis.
    Nemoto Y, Kanai T, Makita S, Okamoto R, Totsuka T, Takeda K, Watanabe M.
    Gastroenterology; 2007 Jan 15; 132(1):176-89. PubMed ID: 17241870
    [Abstract] [Full Text] [Related]

  • 15. Endogenous IL-21 restricts CD8+ T cell expansion and is not required for tumor immunity.
    Søndergaard H, Coquet JM, Uldrich AP, McLaughlin N, Godfrey DI, Sivakumar PV, Skak K, Smyth MJ.
    J Immunol; 2009 Dec 01; 183(11):7326-36. PubMed ID: 19915059
    [Abstract] [Full Text] [Related]

  • 16. Regulatory role of CD8+ T lymphocytes in bone marrow eosinophilopoiesis.
    Rådinger M, Sergejeva S, Johansson AK, Malmhäll C, Bossios A, Sjöstrand M, Lee JJ, Lötvall J.
    Respir Res; 2006 Jun 01; 7(1):83. PubMed ID: 16740158
    [Abstract] [Full Text] [Related]

  • 17. CD8+ T cells induce complete regression of advanced ovarian cancers by an interleukin (IL)-2/IL-15 dependent mechanism.
    Yang T, Wall EM, Milne K, Theiss P, Watson P, Nelson BH.
    Clin Cancer Res; 2007 Dec 01; 13(23):7172-80. PubMed ID: 18056198
    [Abstract] [Full Text] [Related]

  • 18. In vivo antitumor activity of interleukin 21 mediated by natural killer cells.
    Wang G, Tschoi M, Spolski R, Lou Y, Ozaki K, Feng C, Kim G, Leonard WJ, Hwu P.
    Cancer Res; 2003 Dec 15; 63(24):9016-22. PubMed ID: 14695220
    [Abstract] [Full Text] [Related]

  • 19. Intracerebral interleukin 12 induces glioma rejection in the brain predominantly by CD8+ T cells and independently of interferon-gamma.
    Vetter M, Hofer MJ, Roth E, Pircher HP, Pagenstecher A.
    J Neuropathol Exp Neurol; 2009 May 15; 68(5):525-34. PubMed ID: 19525900
    [Abstract] [Full Text] [Related]

  • 20. Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas.
    Nakamizo A, Marini F, Amano T, Khan A, Studeny M, Gumin J, Chen J, Hentschel S, Vecil G, Dembinski J, Andreeff M, Lang FF.
    Cancer Res; 2005 Apr 15; 65(8):3307-18. PubMed ID: 15833864
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.